Apolipoprotein E gene polymorphism, total plasma cholesterol level, and parkinson disease dementia

Archives of Neurology

Volumn 64, Issue 2, 2007, Pages 261-265

  Jasinska Myga, Barbara ^a,b   Opala, Grzegorz ^a   Goetz, Christopher G ^c   Tustanowski, Jerzy ^a   Ochudlo, Stanislaw ^a   Gorzkowska, Agnieszka ^a   Tyrpa, Jadwiga ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Central University Hospital   (Poland)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E GENE; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMENTIA; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ASSAY; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HOSPITAL PATIENT; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; OUTPATIENT; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX RATIO; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 33847007700     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.2.261     Document Type: Article

References (21)

1. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873-880.
2. Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem. 1995;41:1068-1086.
3. Saunders AM, Strittmatter MD, Schmechel MD, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
4. Frisoni GB, Bianchetti A, Govoni S, Trabucchi M, Calabresi L, Franceschini G. Association of apolipoprotein E E4 with vascular dementia [letter]. JAMA. 1994;271:1317.
5. St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A. Apolipoprotein E ε4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett. 1994;176:45-46.
6. Jarvik GP, Wijsman EM, Kukkul WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 1995;45:1092-1096.
7. Notkola IL, Sulkava R, Pekkanen J, et al. Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology. 1998;17:14-20.
8. Romas SN, Tang MX, Burglund L, Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology. 1999;53:517-521.
9. Evans RM, Emsley CL, Gao S, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology. 2000;54:240-242.
10. Wehr H, Parnowski T, Puzynski S, et al. Apolipoprotein E genotype and lipid and lipoprotein levels in dementia. Dement Geriatr Cogn Disord. 2000;11:70-73.
11. Koller WC, Glatt SL, Hubble JP, et al. Apoliporotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol. 1995;37:242-245.
12. Inzelberg R, Chapman J, Treves TA. Apolipoprotein E4 in Parkinson's disease and dementia: new data and meta-analysis of published studies. Alzheimer Dis Assoc Disord. 1998;12:45-48.
13. Camicioli R, Rajput A, Rajput M, Reece C, Payami H, Hao C. Apolipoprotein E4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations. Mov Disord. 2005;20:989-994.
14. Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in Parkinson's disease with or without dementia [comment]. Lancet. 1994;344:889.
15. Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: possible association with dementia but not age of onset. Genomics. 2002;79:458-461.
16. Wakabayashi K, Kakita A, Hayashi A, et al. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Acta Neuropathol (Berl). 1998;95:450-454.
17. Huang X, Chen P, Kaufer DI, Troster AI, Poole C. Apolipoprotein E and dementia in Parkinson's disease. Arch Neurol. 2006;63:189-193.
18. Bednarska-Makaruk M, Broda G, Kurjata P, et al. Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group. Eur J Epidemiol. 2001;17:789-792.
19. Menzel HJ, Kladetzky RG, Assman G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 1983;3:310-315.
20. Frikke-Schmidt R, Wittrup HH, Tybjaerg-Hansen A, Meinertz H, Schnohr P, Nordestgaard BG. Apolipoprotein E genotypes predict attendance rates at lipid clinic. Atherosclerosis. 2000;153:461-468.
21. Larson IA, Ordovas JM, DeLuca C, Barnard JR, Feussner G, Schaefer EJ. Association of apolipoprotein (Apo)E genotype with plasma apo E levels. Atherosclerosis. 2000;148:327-335.